Assenagon Asset Management S.A. bought a new stake in Medidata Solutions Inc (NASDAQ:MDSO) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought 550,086 shares of the company’s stock, valued at approximately $50,333,000. Assenagon Asset Management S.A. owned 0.88% of Medidata Solutions at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Flagship Harbor Advisors LLC raised its position in shares of Medidata Solutions by 58.3% in the second quarter. Flagship Harbor Advisors LLC now owns 475 shares of the company’s stock valued at $42,000 after buying an additional 175 shares during the last quarter. FTB Advisors Inc. boosted its stake in Medidata Solutions by 212.4% during the second quarter. FTB Advisors Inc. now owns 934 shares of the company’s stock worth $84,000 after buying an additional 635 shares during the period. Tower Research Capital LLC TRC boosted its stake in Medidata Solutions by 102.0% during the second quarter. Tower Research Capital LLC TRC now owns 1,697 shares of the company’s stock worth $153,000 after buying an additional 857 shares during the period. Meeder Asset Management Inc. purchased a new position in Medidata Solutions during the second quarter worth about $185,000. Finally, Qube Research & Technologies Ltd purchased a new position in Medidata Solutions during the second quarter worth about $213,000. Hedge funds and other institutional investors own 91.34% of the company’s stock.
NASDAQ:MDSO traded down $0.05 during mid-day trading on Wednesday, hitting $91.93. The stock had a trading volume of 23,655 shares, compared to its average volume of 832,571. The stock has a 50-day simple moving average of $91.65 and a two-hundred day simple moving average of $89.38. The company has a market capitalization of $5.74 billion, a PE ratio of 95.72, a PEG ratio of 6.93 and a beta of 1.22. Medidata Solutions Inc has a twelve month low of $60.10 and a twelve month high of $98.60. The company has a current ratio of 2.56, a quick ratio of 2.56 and a debt-to-equity ratio of 0.27.
Several research analysts have weighed in on MDSO shares. BidaskClub raised shares of Medidata Solutions from a “sell” rating to a “hold” rating in a research note on Tuesday, October 1st. ValuEngine lowered shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Zacks Investment Research raised shares of Medidata Solutions from a “strong sell” rating to a “hold” rating and set a $78.00 target price for the company in a research note on Tuesday, September 24th. Eleven research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $83.71.
Medidata Solutions Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.
Recommended Story: Range Trading
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.